Back to results
CompletedPhase 3

Open-Label Safety Study of ADS-5102 in PD Patients With LID

NCT02202551

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Birmingham, Alabama, United States

+86 additional locations

View on ClinicalTrials.gov
Open-Label Safety Study of ADS-5102 in PD Patients With LID — TrialFind